Grand View Research, Inc.の新刊レポートによると、世界の唾液採取および診断市場の規模は、2030年までに17億ドルに達すると予想されています。市場は、伝染性および非伝染性疾患の有病率の増加に加えて、疾患診断のための非侵襲的方法に対する嗜好が高まっているため、予測期間中は8.4％のCAGRを達成すると推定されます。さらに、COVID-19 に感染した症候性および無症候性の患者を診断する必要性が高まっているため、市場に大きなチャンスが生まれています。2022年8月に PLOS ONEで発表された調査レポートでは、口腔液サンプルはその保存とサンプル採取の容易さから、COVID-19 などのさまざまな診断アッセイに使用できる可能性があると述べられています。さらに、研究者は、唾液サンプルが 28 日以上保存されたとしても、信頼性と有用性が維持されると述べています。
さらに、主に高齢化人口の増加と社会経済的発展により、2020年にはがんとそれに関連する死亡の世界的な負担が増加しました。2020年4月、American Society of Clinical Oncologyに掲載された記事によると、世界中のがんの 50%以上が65歳以上の人々で診断されています。したがって、唾液を用いた検査は、がんを検出するための最良の非侵襲的検査法であると考えられています。2022年8月、OrisDXは、患者の予後を改善するのに役立つ口腔がんを早期に診断および検出するための、唾液ベースの非侵襲的分子検査の開発を発表しました。
非侵襲的サンプリング、簡単でシンプルな採取、および患者のコンプライアンスの向上などによって、臨床および研究用途の両方で唾液サンプルの採用が大幅に増加しています。プロテオミクス分野を前進させるいくつかの進歩と開発が唾液検体で起こっています。たとえば、2022 年 9 月に India Today に掲載された記事では、IIT Roorkee の研究者が、転移性トリプルネガティブ乳がんの予測に役立つ唾液タンパク質を特定したと述べています。
目次
Table of Contents
Chapter 1 Saliva Collection and Diagnostic Market: Methodology And Scope
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
1.7 Global Market: CAGR Calculation
1.8 Regional Market: CAGR Calculation
1.9 List Of Secondary Sources
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.11 List of Abbreviations
Chapter 2 Saliva Collection and Diagnostic Market: Executive Summary
2.1 Saliva Collection and Diagnostic Market: Market Outlook
2.1.1 Market Summary
Chapter 3 Saliva Collection and Diagnostic Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increasing cases of infectious disease
3.3.1.2 Rising application of non-invasive saliva testing method
3.3.2 Market restraint Analysis
3.3.2.1 Lack of skilled professionals to operate saliva collection devices
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
Chapter 4 Saliva Collection and Diagnostic Market: Competitive Landscape
4.1 Recent developments & impact Analysis, by key Market participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market SHARE Analysis, 2021
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
Chapter 5 Saliva Collection and Diagnostic Market: Site of Collection Business Analysis
5.1 Saliva Collection and Diagnostic Market: Site of Collection Movement Analysis
5.2 Parotid Gland Collection
5.2.1 Parotid gland collection Market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Submandibular/Sublingual Gland
5.3.1 Submandibular/Sublingual gland collection Market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Others Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Saliva Collection and Diagnostic Market: Application Business Analysis
6.1 Saliva Collection and Diagnostic Market: Application Movement Analysis
6.2 Disease diagnostics
6.2.1 Disease diagnostics Market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Forensic applications
6.3.1 Forensic applications Market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Research
6.4.1 Research Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Saliva Collection and Diagnostic Market: End-use Business Analysis
7.1 Saliva Collection and Diagnostic Market: End-Use Movement Analysis
7.2 Dentistry
7.2.1 Dentistry Market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Diagnostic Laboratories
7.3.1 Diagnostic laboratories Market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Pharmaceutical & Biotechnology Companies
7.4.1 Pharmaceutical & biotechnology companies Market estimates and forecast, 2018 - 2030 (USD Million)
7.5 Research Institutes
7.5.1 Research institutes Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Saliva Collection and Diagnostic Market: Regional Business Analysis
8.1 Market Share Analysis by Country, 2021 & 2030
8.1.1 North America
8.1.1.1 North America Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.2 U.K.
8.1.2.2.1 U.K. Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.5 Italy
8.1.2.5.1 Italy Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.6 Spain
8.1.2.6.1 Spain Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.3 China
8.1.3.3.1 China Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.4 India
8.1.3.4.1 India Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 South Korea
8.1.3.5.1 South Korea Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.6 Australia
8.1.3.6.1 Australia Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5 Middle East & Africa
8.1.5.1 Middle East & Africa Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.4 UAE
8.1.5.4.1 UAE Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 Saliva Collection and Diagnostic Market: Company Profiling
9.1 Company Profiles
9.1.1 Thermo Fisher Scientific Inc
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Neogen Corporation
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Abbott
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Sarstedt AG & Co.KG
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 Autogen, Inc.
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Oasis Diagnostics
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 Porex
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Salimetrics, LLC
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Takara Bio, Inc.
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
9.1.10 Arcis Bio
9.1.10.1 Company overview
9.1.10.2 Financial performance
9.1.10.3 Product benchmarking
9.1.10.4 Strategic initiatives
9.1.11 Orasure Technologies
9.1.11.1 Company overview
9.1.11.2 Financial performance
9.1.11.3 Product benchmarking
9.1.11.4 Strategic initiatives
9.2 List of Other Key Players
